UNICA IRIS Institutional Research Information System

CARDIA, MARIA CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 166.821
NA - Nord America 5.622
AS - Asia 2.446
SA - Sud America 379
AF - Africa 68
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 175.345
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 164.685
US - Stati Uniti d'America 5.518
CN - Cina 1.091
SG - Singapore 895
UA - Ucraina 543
SE - Svezia 472
DE - Germania 422
BR - Brasile 329
GB - Regno Unito 205
FI - Finlandia 140
VN - Vietnam 123
FR - Francia 96
KR - Corea 85
NL - Olanda 72
IN - India 69
CA - Canada 63
AT - Austria 32
RU - Federazione Russa 27
MA - Marocco 26
PL - Polonia 25
IR - Iran 24
BE - Belgio 20
PK - Pakistan 19
ES - Italia 18
PT - Portogallo 17
BD - Bangladesh 16
JP - Giappone 16
VG - Isole Vergini Britanniche 16
AR - Argentina 15
HK - Hong Kong 15
TR - Turchia 15
MX - Messico 14
IQ - Iraq 12
ZA - Sudafrica 12
ID - Indonesia 10
IE - Irlanda 10
EG - Egitto 8
SA - Arabia Saudita 8
AU - Australia 7
EC - Ecuador 7
KE - Kenya 7
KG - Kirghizistan 7
VE - Venezuela 7
CO - Colombia 6
RO - Romania 6
IL - Israele 5
KZ - Kazakistan 5
LT - Lituania 5
PY - Paraguay 5
TN - Tunisia 5
TW - Taiwan 5
UZ - Uzbekistan 5
CH - Svizzera 4
CR - Costa Rica 4
DK - Danimarca 4
DZ - Algeria 4
HU - Ungheria 4
NP - Nepal 4
PH - Filippine 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
IS - Islanda 3
JO - Giordania 3
MU - Mauritius 3
PA - Panama 3
PE - Perù 3
BO - Bolivia 2
EE - Estonia 2
GE - Georgia 2
GT - Guatemala 2
LK - Sri Lanka 2
MD - Moldavia 2
UY - Uruguay 2
A1 - Anonimo 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BY - Bielorussia 1
CG - Congo 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
GD - Grenada 1
LU - Lussemburgo 1
MY - Malesia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
RS - Serbia 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
UG - Uganda 1
Totale 175.345
Salva come PNG Salva come JPEG
Città #
Cagliari 160.408
Uta 3.107
Chandler 494
Ashburn 480
Singapore 439
Fairfield 429
Woodbridge 371
Dallas 338
Nyköping 315
Jacksonville 298
Boardman 286
Ann Arbor 282
Houston 233
Dearborn 208
Beijing 206
Wilmington 200
Seattle 172
Cambridge 134
New York 124
Santa Clara 106
Los Angeles 104
Hefei 100
Shanghai 97
Nanjing 93
Seoul 84
Milan 67
Boston 65
Helsinki 57
Rome 50
Guangzhou 44
Buffalo 39
Nanchang 38
The Dalles 38
Munich 37
Ho Chi Minh City 35
Toronto 35
Shenyang 34
Redwood City 33
São Paulo 29
Vienna 28
Changsha 25
Hanoi 24
Parma 24
Chicago 22
Dong Ket 22
San Diego 22
Verona 21
Casablanca 20
Hebei 20
Naples 20
Tianjin 20
Jinan 19
Brussels 18
Jiaxing 18
Nürnberg 18
Redondo Beach 18
Road Town 16
Sassari 16
London 15
Amsterdam 14
Florence 14
Orange 14
Tokyo 14
Denver 13
Montreal 13
Mountain View 13
Norwalk 13
Auburn Hills 12
Hong Kong 12
Orem 12
Padova 12
Warsaw 12
Atlanta 11
Catania 11
Council Bluffs 11
Stockholm 11
Turku 11
Bologna 10
Brooklyn 10
Frankfurt am Main 10
Hangzhou 10
Nuremberg 10
Rende 10
Rio de Janeiro 10
Augusta 9
Bari 9
Kunming 9
Lodz 9
Turin 9
Zhengzhou 9
Cosenza 8
Herndon 8
Johannesburg 8
Lauterbourg 8
Taizhou 8
Washington 8
Wuhan 8
Bishkek 7
Dublin 7
Genoa 7
Totale 170.539
Salva come PNG Salva come JPEG
Nome #
Inhalable polymer-glycerosomes as safe and effective carriers for rifampicin delivery to the lungs 4.568
Formulation and characterization studies of trimethyl chitosan / sodium alginate nanoparticles for targeted drug delivery 4.561
3-Acetyl-2,5-diaryl-2,3-dihydro-1,3,4-oxadiazoles: A new scaffold for the selective inhibition of monoamine oxidase B 4.277
Nanoincorporation of curcumin in polymer-glycerosomes and evaluation of their in vitro-in vivo suitability as pulmonary delivery systems 3.890
Investigating the interactions of resveratrol with phospholipid vesicle bilayer and the skin: NMR studies and confocal imaging 3.864
A novel series of 3,4-disubstituted dihydropyrazoles: Synthesis and evaluation for MAO enzyme inhibition 3.733
Preparazione di nanoparticelle di TMC per il rilascio di farmaci a livello oculare 3.469
Preparation and characterization of TMC nanoparticles for colon specific drug delivery 3.444
Identification of HIV-1 reverse transcriptase dual inhibitors by a combined shape-, 2D-fingerprint- and pharmacophore-based virtual screening approach 3.436
Sintesi e caratterizzazione chimico-fisica di un derivato del chitosano per la realizzazione di sistemi nanoparticellari 3.414
Design and synthesis of new isatin derivatives as HIV-1 reverse transcriptase associated ribonuclease H inhibitors 3.287
Synthesis And Characterization Of A Chitosan Derivative For The Preparation Of Nanoparticles 3.238
Synthesis and biological assessment of novel 2-thiazolylhydrazones and computational analysis of their recognition by monoamine oxidase B 3.228
PREPARATION OF TMC NANOPARTICLES FOR OCULAR DELIVERY 3.209
Synthesis of new 3-aryl-4,5-dihydropyrazole-1-carbothioamide derivatives. An investigation on their ability to inhibit monoamine oxidase 3.178
Physico-chemical characterization of succinyl chitosan-stabilized liposomes for the oral co-delivery of quercetin and resveratrol 2.986
Trimethyl chitosan hydrogel nanoparticles for progesterone delivery in neurodegenerative disorders 2.936
NANOPARTICELLE A BASE DI TMC E SA PER LA VEICOLAZIONE NOSE TO BRAIN 2.788
SINTESI DI TMC A DIVERSO GRADO DI QUATERNIZZAZIONE PER LA REALIZZAZIONE DI SISTEMI NANOPARTICELLARI 2.750
null 2.749
3-[2-(4-aryl-1,3-thiazol-2-yl)hydrazin-1-ylidene]-1H-indol-2-ones as new potential dual inhibitors of polimerase and ribonuclease HIV-1 RT associated function 2.580
PREPARAZIONE E CARATTERIZZAZIONE DI SISTEMI NANOPARTICELLARI DI TMC PER LA VEICOLAZIONE DI UN AGENTE ANTINFIAMMATORIO FITOTERAPICO MIRATO AL COLON 2.578
Synthesis and characterization of new phthalhydrazothiazole derivatives: A preliminary investigation on their activity against hepatocellular carcinoma 2.493
Chalcones as novel dual inhibitors of HIV-1 reverse transcriptase 2.419
1H NMR study of the interaction of trans-resveratrol with soybean phosphatidylcholine liposomes 2.368
Preparazione e caratterizzazione di formulazioni cosmetiche contenenti olio di Neem 2.345
Nanoparticelle per la veicolazione nasale del Progesterone per il trattamento della malattia di Alzheimer 2.306
SYNTHESIS AND CHARACTERIZATION OF A CHITOSAN DERIVATIVE FOR THE PREPARATION OF NANOPARTICLES 2.275
New promising scaffolds for the inhibition of monoamine oxidase B 2.271
Preparation and Characterization of TMC/SA nanoparticles for nose to brain drug delivery 2.251
Exploring new scaffolds for the inibition of the Ribonuclease H function of RT HIV-1 2.230
Terapia delle infezioni sostenute da Candida spp.: nuovi approcci mediante derivati isotiosemicarbazonici. 2.137
Design and synthesis of new Isatin derivatives as HIV-1 Reverse Transcriptase associated Ribonuclease H inhibitors twenty-fourth 2.125
Approcci formulativi per ottimizzare l’incapsulazione nanoparticellare della Curcumina 2.096
In vitro activity of 2-cyclohexylidenhydrazo-4-phenil-thiazole compared with those of amphotericin b and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans 2.073
Design, synthesis and biolgical activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 2.046
Needle-Free Jet Injectors and Nanosuspensions: Exploring the Potential of an Unexpected Pair 1.984
null 1.949
Design, synthesis and biological activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 1.930
Synthesis and anti-microbial activity evaluation of some new 1-benzoyl-isothiosemicarbazides. 1.899
Identification of HIV-1 reverse trascriptase dual inhibitors by a combined shape-, 2D fingerprint and pharmacophore-based virtual screening approch 1.898
Nanosuspension-Based Dissolvable Microneedle Arrays to Enhance Diclofenac Skin Delivery 1.877
Design of new inhibitors of the HIV-1 Reverse Transcriptase associated Ribonuclease H function: a synthetic approach 1.850
Synthesis, semipreparative HPLC separation, biological evaluation, and 3D-QSAR of hydrazothiazole derivatives as human monoamine oxidase B inhibitors 1.839
Identification of new scaffolds for the inhibition of HIV-1 Reverse Transcriptase associated Ribonuclease H function by means of shape based similarity screening 1.770
Exploring new scaffolds for the inhibition of the Ribonuclease H function of RT HIV-1 1.671
SYNTHESIS, MOLECULAR MODELLING, INHIBITORY ACTIVITY, AND SELECTIVITY TOWARDS MONOAMINE OXIDASE OF NEW HETEROCYCLIC SCAFFOLDS 1.656
Synthesis and anti-microbial activity of isothiosemicarbazones and cyclic analogues 1.637
Synthesis and antimicrobial activity of novel arylidenisothiosemicarbazones 1.635
Attività fungicida di analoghi ciclici isotiosemicarbazonici nei confronti di isolati clinici di Candida spp. 1.612
Effetti sulla attività di AmB nei confronti di biofilm di C. albicans in seguito ad esposizione a EM01D2 e fluconazolo. 1.561
Repurposing Pomalidomide as a Neuroprotective Drug: Efficacy in an Alpha-Synuclein-Based Model of Parkinson's Disease 1.553
Derivati ciclici isotiosemicarbazonici come approccio alternativo nella terapia delle infezioni sostenute da Candida spp. 1.435
Transcutol® p containing slns for improving 8-methoxypsoralen skin delivery 1.422
null 1.415
null 1.406
Shape based computer aided similarity screening: a valid tool in the discovery of new scaffolds for the inhibition of HIV-1 reverse transcriptase associated ribonuclease H function 1.383
Synthesis of new arylidencycloalkylpyrazoles of potential biological interest 1.153
An investigation of the biological effect of structural modifications of isothiosemicarbazones and their cyclic analogues 1.090
Synthesis, molecular modelling, inhibitory acivity, and selectivity towards monoamine oxidase of new heterocyclic scaffold 1.083
Preparazione di nanoparticelle TMC/Alginato per la veicolazione al SNC 1.080
Characterization of 2,5-diaryl-1,3,4-oxadiazolines by multinuclear magnetic resonance and DFT calculations. Investigation on a case of very remote Hammett correlation 1.068
Synthesis and biological evaluation of some differently substituted 9,10-anthracenediones 1.017
Progettazione e sintesi di 4-(5-ariliden-3-metil-4-ossotiazolidin-2-ilidenamino)benzensulfonamidi e 4-(5-alchiliden-3-metil-4-ossotiazolidin-2-ilidenammino)benzensulfonamidi quali potenziali inibitori selettivi delle ciclossigenasi 2 1.011
Proniosomal formulation encapsulating pomegranate peel extract for nutraceutical applications 1.003
Computational approaches for discovery and optimization of monoamine oxidase B inhibitors 992
Synthesis and antimicrobial activity of novel arylideneisothiosemicarbazones 945
null 943
Pulmonary delivery of curcumin and beclomethasone dipropionate in a multicomponent nanosuspension for the treatment of bronchial asthma 943
1-benzenesulfonamide-1(H)-pyrazoles and 3-benzenesulfonamide-4-tiazolidinones, two promising scaffolds for the design of cycloxygenase inhibitors 934
CoMFA studies of non-covalent monoamine oxidase inhibitors 912
Tri-substituted thiazolines as promising scaffolds for the design of efficient COX inhibitors 899
Combining induced fit docking and molecular dynamics simulations to predict the binding mode of new monoamine oxidase B inhibitors 883
1-acetyl-2,5-diaryl-2,3-dihydro-1,3,4-oxadiazole; a new scaffold for monoaminoxidase inhibitors: design, synthesis, and biological properties 868
Attività di un derivato isotiosemicarbazonico ciclico nei confronti di biofilm di Candida albicans FLC-S e FLC-R in combinazione con AMB 865
Sintesi di cicloalchilidenidrazo-4-ariltiazoli ad elevata attività inibitrice selettiva sulla isoforma B delle monoammino ossidasi 863
Computational and experimental study of non-covalent monoamine oxidase inhibitors 848
Synthesis, molecular modeling studies and selective inhibitory activity against MAO of N1-propanoyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives 835
Novel MAO-B selective inhibitors developed using computational methods 835
null 818
Aumento della sensibilità all’AmB di biofilm di Candida albicans fluconazolo-resistente nell’impiego combinato con derivati ciclici isotiosemicarbazonici 803
Topoisomerase I: synthesis of a new class of potential inhibitors 799
Impact of solid lipid nanoparticles on 3T3 fibroblasts viability and lipid profile: The effect of curcumin and resveratrol loading 735
Studio dell’attività di analoghi ciclici isotiosemicarbazonici nei confronti di isolati clinici di Aspergillus spp 735
null 735
null 693
Strategie alternative per la profilassi delle infezioni sostenute da Candida albicans contratte in ambiente ospedaliero mediante isotiosemicarbazoni ciclici 676
Isothiosemicarbazones as alternative approach to the therapy of infections sustained by Candida albicans 667
Studio della attività di una nuova classe di isotiosemicarbazoni nei confronti di Aspergillus spp. di isolamento clinico. 638
null 617
null 610
Nanocrystals as an effective strategy to improve Pomalidomide bioavailability in rodent 585
Synthesis of new arylidencycloalkylpyrazoles of biological interest 580
Bentonite- and Palygorskite-Based Gels for Topical Drug Delivery Applications 498
Isonicotinoylhydrazothiazoles and isonicotinoyl-N-4-substituted thiosemicarbazides: Synthesis, characterization, and anti-mycobacterial activity 459
Characterization of 2,5-diaryl-1,3,4-oxadiazolines by multinuclear magnetic resonance and density functional theory calculations. Investigation on a case of very remote Hammett correlation 444
Clay-Based Hydrogels as Drug Delivery Vehicles of Curcumin Nanocrystals for Topical Application 410
Selective inhibitory activity against MAO and molecular modeling studies of 2-thiazolylhydrazone derivatives 378
New cycloalkylpyrazoles as potential cyclooxygenase inhibitors 372
Synthesis, Molecular Modeling Studies, and Selective Inhibitory Activity against Monoamine Oxidase of 1-Thiocarbamoyl-3,5-diaryl-4,5-dihydro-(1H)- pyrazole Derivatives 298
Totale 174.600
Salva come PNG Salva come JPEG
Categoria #
all - tutte 208.601
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 208.601
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202117.345 0 0 0 0 0 4.334 3.610 2.304 1.159 2.327 2.291 1.320
2021/20227.147 991 765 320 378 597 490 481 334 590 590 805 806
2022/202312.131 945 1.574 1.399 1.156 816 1.103 753 965 670 997 1.198 555
2023/202413.892 494 654 1.153 916 1.496 2.115 2.025 1.026 819 715 1.134 1.345
2024/202522.055 3.608 4.952 5.648 2.362 1.250 1.438 1.603 154 255 209 239 337
2025/20263.133 476 292 774 630 487 474 0 0 0 0 0 0
Totale 175.574